Peer Review History
| Original SubmissionDecember 9, 2024 |
|---|
|
Dear Dr. Valladares-Garrido, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Thank you for submitting your manuscript to PLOS ONE. The study addresses a highly relevant topic by exploring smartphone dependence, insomnia, and their association with mental health and behavioral patterns, particularly in the context of medical students during the COVID-19 pandemic. The research design is sound, and the findings provide meaningful insights that contribute to the growing body of literature in this field. After carefully considering the feedback provided by the reviewers, it is evident that while the comments individually suggest minor adjustments, their cumulative scope indicates the need for a more thorough revision. This decision is not a reflection of any fundamental issues with your work but rather an opportunity to ensure that the manuscript meets the highest standards of clarity, methodological transparency, and interpretative rigor. We suggest expanding the introduction to include additional literature on behavioral addiction and its relationship with mental health conditions. This will help contextualize the study within the broader research landscape and better articulate the research gap your study aims to address. Highlighting the novelty of your approach and findings will strengthen the manuscript further. In the methods section, please provide greater detail on the sampling strategy, including the number of universities selected, and elaborate on the exclusion process that led to the final sample size. It would also be helpful to clarify how confounding variables, such as nutritional status, were identified and measured, as well as how the adjustments were applied during the analysis. Additionally, we recommend reorganizing the section to separate the description of scales and instruments from operational definitions, which could be included as a distinct subsection for improved readability. The ethical considerations require clarification, specifically regarding the type of consent obtained from participants. This information should be included explicitly to align with ethical guidelines and ensure transparency. In the results section, address the discrepancies between the methods and results regarding the categorization of variables such as depression and anxiety. Additionally, refine the interpretation of prevalence ratios to provide a clearer understanding of the findings. Finally, the discussion would benefit from a deeper reflection on the implications of your findings in addressing the research gap and contributing to future work in this area. Explicit acknowledgment of the methodological limitations, including potential selection biases and the rationale for excluding certain clinical conditions, will enhance the manuscript’s rigor and balance. We recognize the effort that has already gone into this study and appreciate its potential to contribute meaningfully to the field. We look forward to receiving your revised manuscript and are confident that these changes will further strengthen the work. ============================== Please submit your revised manuscript by Feb 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Juan Luis Castillo-Navarrete, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: Please read the attached annotated manuscript for comments. The manuscript details findings on associations between various count data variables, namely, smartphone dependence and insomnia and associated sociodemographic variables. Whilst there is nothing inherently problematic in the manuscript, the amount of new information to the area is adequate. Self-reported student stress and smartphone time consumption are significantly associated but this finding is not novel nor unexecpted. Nonetheless, the research design and statistical analyses is correct and the authors do not move beyond what the data suggests. Reviewer #2: In the introduction section, authors have mentioned limited literature related to the study, they are suggested to add more on behavioral addiction and smart phone addition and its association with mental health conditions. In method section (line no. 97-100), authors mentioned “we acknowledge the inherent limitations of this method, including the potential for selection bias, which may limit the generalizability of our findings. A discussion of these limitations is provided in the results and discussion sections.” This should only be mentioned in the limitation section of the study. Line 114 and 115, authors have mentioned that “they excluded people who had a doctor's diagnosis of depression, or who had been treated with antidepressants in the previous year. How about anxiety and other clinical conditions, why only excluding depression. As we know that during pandemic more anxiety was reported then depression, kindly clarify this. Authors are requested to give description of scales/instruments in subsection separately. They are requested to mention the operational definitions separately at the end of method section, it should not be mixed up with the description of scales/instruments. Reviewer #3: 1. In Ethics statement, please "indicate the form of consent obtained" 2. Please find the comments for given line numbers below: Line 95. How many universities were selected? Were all universities in Peru included? If not, what sampling strategy was used? Line 116. How many participants were included in the survey? And how many were excluded to reach the final sample size of 370? Line 157. I suppose, 15-19 should be categorized as 'moderately severe' instead of 'moderate'. Line 164. Details on confounding variables could be elaborated. For example, how was the nutritional status measured? Also, were the assumptions of poisson regression met? Line 175. How were the confounding variables identified, and how was the minimal set of adjusted confounders determine? (e.g. using DAG or any models) Line 180. I suppose, the participants provided a written consent. Line 199. In the methods section, it says that depression was a categorical variable. However, in the results, it is presented as a dichotomous variable. Could you explain how it was dichotomized? Same for anxiety, the methods section does not explain how the variable anxiety was treated. Line 217. Since you are reporting exp beta, an interpretation like this "The prevalence of insomnia was 1.9 times higher among individuals with smartphone dependence compared to those without dependence" may be better than saying "more likely to" (as it sounds more like interpreting likelihood) Line 223. Since you are talking about the frequency of insomnia, are you referring to table 2? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Salman Shahzad Reviewer #3: Yes: Supriya Sherpa ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Valladares-Garrido, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The authors used both the terms dependence and addiction in the text. Somewhere they are distinct and somewhere they are interchanged. I would suggest to change this to avoid confusion and to use only one term or to clearly explain the difference between then in the text. The SDAS cutoff points are pooled from the sample so they are sample dependent. They don't give absolute numbers which would be more sample independent. I would like to see more explanation abut this. With that kind of cutoff points any sample would produce both addictive and non-addictive participants. The authors wrote `We found that smartphone dependence increased the prevalence of insomnia by 44.2%.` This result is from chi square test of association, so we can not draw conclusion what is the cause. Maybe it was the other way round or some third factor influencing both of those. The authors should change the language used to describe this result. Sincerely, Academic Editor ============================== Please submit your revised manuscript by Jul 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Pavle Randjelovic, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes ********** Reviewer #4: Thank you for the opportunity to review the manuscript entitled "Smartphone dependence, addiction, and insomnia among medical students during the COVID-19 pandemic" (Manuscript ID: PONE-D-24-56765). The manuscript addresses an important and timely topic, particularly given the global reliance on digital devices and the mental health challenges exacerbated by the COVID-19 pandemic. Overall Assessment: The study is well-structured, the statistical analysis is appropriate, and the discussion is grounded in relevant literature. The use of validated instruments (ISI, PHQ-9, GAD-7, and SDAS) strengthens the methodological rigor, and the findings contribute meaningfully to the existing knowledge on smartphone dependence and sleep health in medical student populations. Strengths: The large sample size (n = 370) provides adequate power for the analyses. Adjustments for potential confounders such as depression and anxiety enhance the internal validity of the results. The study uses a well-defined and operationalized construct of smartphone dependence and addiction using a validated scale adapted for Spanish-speaking populations. Areas for Improvement: Clarity on Secondary Analysis: While the authors mention this is a secondary analysis of previously collected data (ref [21]), greater clarity should be provided regarding the original study’s objectives, overlap in variables analyzed, and the novelty of this manuscript’s specific focus. This is essential to fully assess the extent of original contribution and avoid concerns of salami publication or dual submission. Sampling and Generalizability: The convenience sampling strategy and use of WhatsApp groups may limit generalizability. While this is acknowledged in the discussion, it may be helpful to provide more context or comparison with national student demographics to assess representativeness. Data Availability: The manuscript states “All relevant data are within the manuscript and its Supporting Information files.” However, it would be helpful to explicitly indicate where the datasets can be accessed or whether any anonymized data files are provided for replication purposes. Ethical Considerations: The authors adequately describe IRB approval and informed consent. However, it would strengthen the ethical narrative to specify whether participants were compensated (monetarily or through academic credits) and confirm that participation did not influence course evaluations or academic standing. Language and Formatting: A few sections would benefit from minor editorial revisions for clarity and flow, particularly in the Methods and Discussion. For instance, "not single" could be more clearly described as "married or in a relationship." Future Directions: While the authors suggest longitudinal and comparative studies in the future, it may be valuable to highlight the potential of interventions (e.g., smartphone use reduction strategies or sleep hygiene programs) that could stem from this evidence. Ethics and Integrity: There are no apparent concerns related to research misconduct or unethical practices. The ethics approval is clearly stated (CEI-EPM-UCV-2020), and there is no indication of duplicate publication at this time. However, the authors should ensure that the current manuscript provides distinct contributions relative to the prior publication (ref [21]). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: Yes: Carlos Miguel Rios-Gonzalez ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Smartphone dependence, addiction, and insomnia among medical students during the COVID-19 pandemic PONE-D-24-56765R2 Dear Dr. Valladares-Garrido, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Pavle Randjelovic, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #4: Yes ********** Reviewer #4: The manuscript now meets the requirements for publication, as all reviewer comments have been thoroughly addressed ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #4: Yes: Carlos Miguel Rios-Gonzalez ********** |
| Formally Accepted |
|
PONE-D-24-56765R2 PLOS ONE Dear Dr. Valladares-Garrido, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Pavle Randjelovic Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .